AsiaMedic Limited (SGX: 505)
Singapore
· Delayed Price · Currency is SGD 0.0120
+0.0010 (9.09%)
At close: Nov 25, 2024
AsiaMedic Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 26.03 | 23.6 | 18.88 | 18.26 | 15.28 | 18.99 | Upgrade
|
| Other Revenue | 0.16 | 0.15 | 0.16 | 0.17 | 0.1 | 0.07 | Upgrade
|
| Revenue | 26.19 | 23.75 | 19.04 | 18.42 | 15.38 | 19.06 | Upgrade
|
| Revenue Growth (YoY) | 23.10% | 24.72% | 3.38% | 19.81% | -19.32% | 0.15% | Upgrade
|
| Cost of Revenue | 21.21 | 18.4 | 14.78 | 14.25 | 12.88 | 15.14 | Upgrade
|
| Gross Profit | 4.97 | 5.35 | 4.27 | 4.17 | 2.49 | 3.92 | Upgrade
|
| Selling, General & Admin | 0.11 | 0.11 | 0.14 | 0.14 | 0.16 | 0.13 | Upgrade
|
| Other Operating Expenses | 2.51 | 2.45 | 2.15 | 1.97 | 1.81 | 1.99 | Upgrade
|
| Operating Expenses | 4.87 | 4.63 | 3.34 | 3.38 | 4.64 | 4.62 | Upgrade
|
| Operating Income | 0.11 | 0.72 | 0.92 | 0.79 | -2.14 | -0.7 | Upgrade
|
| Interest Expense | -0.47 | -0.42 | -0.24 | -0.15 | -0.2 | -0.46 | Upgrade
|
| Interest & Investment Income | 0.18 | 0.17 | 0.04 | 0.02 | 0.05 | 0.01 | Upgrade
|
| Earnings From Equity Investments | 0.35 | 0.44 | 0.48 | 0.36 | 0.37 | 0.56 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 0.09 | -0 | -0 | Upgrade
|
| EBT Excluding Unusual Items | 0.17 | 0.91 | 1.21 | 1.12 | -1.92 | -0.59 | Upgrade
|
| Impairment of Goodwill | - | - | -0.52 | - | - | - | Upgrade
|
| Asset Writedown | 0.12 | 0.12 | 1.5 | -0.86 | -4.19 | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.45 | 1.82 | - | Upgrade
|
| Pretax Income | 0.29 | 1.03 | 2.19 | 0.72 | -4.3 | -0.59 | Upgrade
|
| Income Tax Expense | -0.89 | -0.89 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | 1.19 | 1.92 | 2.19 | 0.72 | -4.3 | -0.59 | Upgrade
|
| Net Income | 1.19 | 1.92 | 2.19 | 0.72 | -4.3 | -0.59 | Upgrade
|
| Net Income to Common | 1.19 | 1.92 | 2.19 | 0.72 | -4.3 | -0.59 | Upgrade
|
| Net Income Growth | -54.94% | -12.13% | 205.72% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 1,150 | 1,132 | 1,120 | 1,120 | 1,094 | 392 | Upgrade
|
| Shares Outstanding (Diluted) | 1,150 | 1,132 | 1,120 | 1,120 | 1,094 | 392 | Upgrade
|
| Shares Change (YoY) | 2.69% | 1.13% | - | 2.36% | 178.90% | 0.20% | Upgrade
|
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | -0.00 | Upgrade
|
| EPS Growth | -56.15% | -13.11% | 225.88% | - | - | - | Upgrade
|
| Free Cash Flow | -1.05 | 0.98 | 0.23 | 3.06 | 1.98 | -0.08 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | Upgrade
|
| Gross Margin | 18.99% | 22.52% | 22.40% | 22.65% | 16.22% | 20.56% | Upgrade
|
| Operating Margin | 0.41% | 3.03% | 4.85% | 4.31% | -13.95% | -3.66% | Upgrade
|
| Profit Margin | 4.53% | 8.09% | 11.48% | 3.88% | -27.93% | -3.09% | Upgrade
|
| Free Cash Flow Margin | -3.99% | 4.14% | 1.23% | 16.60% | 12.89% | -0.43% | Upgrade
|
| EBITDA | 0.97 | 1.6 | 1.19 | 1.17 | -0.94 | 0.14 | Upgrade
|
| EBITDA Margin | 3.70% | 6.74% | 6.24% | 6.35% | -6.14% | 0.73% | Upgrade
|
| D&A For EBITDA | 0.86 | 0.88 | 0.27 | 0.38 | 1.2 | 0.84 | Upgrade
|
| EBIT | 0.11 | 0.72 | 0.92 | 0.79 | -2.14 | -0.7 | Upgrade
|
| EBIT Margin | 0.41% | 3.03% | 4.85% | 4.31% | -13.95% | -3.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.